JP2019509717A5 - - Google Patents

Download PDF

Info

Publication number
JP2019509717A5
JP2019509717A5 JP2018538718A JP2018538718A JP2019509717A5 JP 2019509717 A5 JP2019509717 A5 JP 2019509717A5 JP 2018538718 A JP2018538718 A JP 2018538718A JP 2018538718 A JP2018538718 A JP 2018538718A JP 2019509717 A5 JP2019509717 A5 JP 2019509717A5
Authority
JP
Japan
Prior art keywords
residue
amino acid
polymerase
position corresponding
acid substitution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018538718A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019509717A (ja
JP6934477B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/014082 external-priority patent/WO2017127510A2/en
Publication of JP2019509717A publication Critical patent/JP2019509717A/ja
Publication of JP2019509717A5 publication Critical patent/JP2019509717A5/ja
Priority to JP2021135313A priority Critical patent/JP7256849B2/ja
Application granted granted Critical
Publication of JP6934477B2 publication Critical patent/JP6934477B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018538718A 2016-01-19 2017-01-19 熱安定逆転写酵素 Active JP6934477B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021135313A JP7256849B2 (ja) 2016-01-19 2021-08-23 熱安定逆転写酵素

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662280451P 2016-01-19 2016-01-19
US62/280,451 2016-01-19
PCT/US2017/014082 WO2017127510A2 (en) 2016-01-19 2017-01-19 Thermostable reverse transcriptase

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021135313A Division JP7256849B2 (ja) 2016-01-19 2021-08-23 熱安定逆転写酵素

Publications (3)

Publication Number Publication Date
JP2019509717A JP2019509717A (ja) 2019-04-11
JP2019509717A5 true JP2019509717A5 (https=) 2020-02-27
JP6934477B2 JP6934477B2 (ja) 2021-09-15

Family

ID=59362774

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018538718A Active JP6934477B2 (ja) 2016-01-19 2017-01-19 熱安定逆転写酵素
JP2021135313A Active JP7256849B2 (ja) 2016-01-19 2021-08-23 熱安定逆転写酵素

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021135313A Active JP7256849B2 (ja) 2016-01-19 2021-08-23 熱安定逆転写酵素

Country Status (4)

Country Link
US (3) US10323243B2 (https=)
EP (2) EP3405578B1 (https=)
JP (2) JP6934477B2 (https=)
WO (1) WO2017127510A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6934477B2 (ja) 2016-01-19 2021-09-15 ボード オブ リージェンツ ザ ユニヴァーシティ オブ テキサス システム 熱安定逆転写酵素
EP3720606A4 (en) * 2017-07-27 2021-05-05 Board Of Regents, The University Of Texas System AMPLIFICATION OF PAIRED PROTEINCODING MRNA SEQUENCES
WO2019084538A1 (en) * 2017-10-27 2019-05-02 Board Of Regents, The University Of Texas System TUMOR SPECIFIC ANTIBODIES, T CELL RECEPTORS AND METHODS OF IDENTIFICATION THEREOF
JP7593316B2 (ja) * 2019-07-26 2024-12-03 東洋紡株式会社 安定性に優れた変異型逆転写酵素
WO2024238992A1 (en) * 2023-05-18 2024-11-21 10X Genomics, Inc. Engineered non-strand displacing family b polymerases for reverse transcription and gap-fill applications
US12467041B2 (en) 2023-12-12 2025-11-11 Hubei University Pfu DNA polymerase mutants with reverse transcriptase activity and their applications
CN117778348B (zh) * 2023-12-12 2024-09-20 湖北大学 一种具有逆转录酶活性的Pfu DNA聚合酶突变体及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040009486A1 (en) * 1999-10-29 2004-01-15 Sorge Joseph A. Compositions and methods utilizing DNA polymerases
US20030228616A1 (en) 1999-10-29 2003-12-11 Stratagene DNA polymerase mutants with reverse transcriptase activity
DE60141097D1 (de) * 2000-05-11 2010-03-11 Toyo Boseki Modifizierte thermostabile dna polymerase von pyrococcus kodakaraensis
GB0022458D0 (en) 2000-09-13 2000-11-01 Medical Res Council Directed evolution method
US20030134292A1 (en) * 2001-10-30 2003-07-17 Farchaus Joseph W. Thermostable DNA polymerases and methods of making same
ATE427992T1 (de) * 2001-11-14 2009-04-15 Toyo Boseki Dna-synthesepromotoren, mit dna-polymerase assoziierte faktoren und nutzung davon
US7932070B2 (en) * 2001-12-21 2011-04-26 Agilent Technologies, Inc. High fidelity DNA polymerase compositions and uses therefor
US7148049B2 (en) * 2002-04-02 2006-12-12 Roche Molecular Systems, Inc. Thermostable or thermoactive DNA polymerase molecules with attenuated 3′-5′ exonuclease activity
GB0325653D0 (en) 2003-11-03 2003-12-10 Medical Res Council CST emulsions
EP1801213A3 (en) 2003-11-03 2007-10-24 Medical Research Council Polymerase
US20070048748A1 (en) * 2004-09-24 2007-03-01 Li-Cor, Inc. Mutant polymerases for sequencing and genotyping
ES2404665T3 (es) 2006-09-06 2013-05-28 Medical Research Council Polimerasas de ADN que incorporan análogos de nucleótidos marcados con colorante
US20090305345A1 (en) 2006-10-23 2009-12-10 Medical Research Council Polymerase
CA2742593C (en) * 2008-11-03 2020-05-05 Kapa Biosystems, Inc. Chimeric dna polymerases
US20110301041A1 (en) * 2010-02-26 2011-12-08 Life Technologies Corporation Modified Proteins and Methods of Making and Using Same
GB201007384D0 (en) * 2010-04-30 2010-06-16 Medical Res Council Enzymes
JP6934477B2 (ja) 2016-01-19 2021-09-15 ボード オブ リージェンツ ザ ユニヴァーシティ オブ テキサス システム 熱安定逆転写酵素

Similar Documents

Publication Publication Date Title
JP2019509717A5 (https=)
WO2015196150A3 (en) Mutations that confer genetic stability to additional genes in influenza viruses
FI3526323T3 (fi) Hepatiitti B -viruksen genomissa oleville tunnistussekvensseille spesifisiä muokattuja meganukleaaseja
MX2019006943A (es) Polipéptidos para manejo de infecciones virales.
JP2015154787A5 (https=)
MX377983B (es) Análogos de nucleótidos.
MX2022006652A (es) Proteinas de capside modificadas para un suministro mejorado de vectores de parvovirus.
FR2981088B1 (fr) Arn polymerases mutees
MY197236A (en) 2'-substituted-n6-substituted purine nucleotides for rna virus treatment
MX2017016105A (es) Polinucleotidos y polipeptidos de adenovirus.
PH12015502799A1 (en) Substituted nucleosides, nucleotides and analogs thereof
WO2014202616A3 (en) Rasamsonia gene and use thereof
NZ594355A (en) Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
WO2016046234A3 (en) Recombinant phe-free proteins for use in the treatment of phenylketonuria
MD4760B1 (ro) Compoziţii şi metode de tratament al infecţiilor provocate de viruşii hepatitei B şi hepatitei D
EA202190454A1 (ru) Новый crispr-ассоциированный белок и его применение
WO2020109780A3 (en) Polypeptide and uses thereof
MY194351A (en) Recombinant Human-Basic Fibroblast Growth Factor (Rh-Bfgf) and Pharmaceutical Composition Comprising Rh-Bfgf
PH12017550134A1 (en) Il-37 variants
MX2018005462A (es) Composiciones inmunogénicas de rsv quimérico y métodos de uso.
MX2017006748A (es) Composiciones de aminoácidos para el tratamiento de síntomas de enfermedades.
DK4069729T3 (da) Optimerede, modificerede meganukleaser med specificitet for en genkendelsessekvens i hepatitis b-virusgenomet
WO2017021471A8 (en) Methods for amplifying and sequencing the genome of a hepatitis c virus
MX2018003162A (es) Variante en el numero de copias que genera resistencia a virus.
WO2017060318A3 (en) Kaurenoic acid hydroxylases